Skip to main content
Clinical Trials/NCT03821831
NCT03821831
Terminated
Not Applicable

Residual Pediatric Obstructive Sleep Apnea: Closing the Treatment Gap

University of Alberta1 site in 1 country8 target enrollmentDecember 3, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric Obstructive Sleep Apnea
Sponsor
University of Alberta
Enrollment
8
Locations
1
Primary Endpoint
Measure of change in OSA severity
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to evaluate the potential improvement of sleep quality in children who have residual obstructive sleep apnea, using either an orthodontic intervention or continuous positive airway pressure (CPAP), versus no treatment.

Detailed Description

Consenting patients and their parents will choose one of three options (within the context of medical/craniofacial appropriateness): CPAP, orthodontic intervention, or to remain untreated (control). It would be ideal if each patient was randomly assigned to one of three groups. However, in our study, random allocation is not an option as the established clinical pathways for treatment, financial resources, and physiological presentation of the patient determines the appropriate intervention. In each group, the effectiveness of the intervention will be analyzed through the evaluation of sleep parameters, medical history, questionnaire responses, craniofacial characteristics, diet, and metabolomic markers, each at baseline and at 12 months.

Registry
clinicaltrials.gov
Start Date
December 3, 2021
End Date
May 8, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with obstructive sleep apnea by polysomnography who presented with a failure in treatment with surgical removal of the tonsils and adenoid tissue --adenotonsillectomy (T\&A).
  • Patients diagnosed with obstructive sleep apnea but for whom T\&A was not an option following assessment by Otolaryngology.

Exclusion Criteria

  • Autism spectrum
  • Down syndrome
  • Pulmonary hypertension
  • Cystic fibrosis

Outcomes

Primary Outcomes

Measure of change in OSA severity

Time Frame: baseline and 12 months

Change from baseline Apnea-Hypopnea Index (OSA severity index) measurement by polysomnography at 12 months

Change from baseline total score Pediatric Sleep Questionnaire (PSQ) at 12 months

Time Frame: baseline and 12 months

PSQ consists of total 22 questions with choices of answer; Yes or No. Yes answer will be coded as 1 and No answer coded as 0. Sum of 22 questions will be compared.

Secondary Outcomes

  • Change from baseline body mass index (BMI) at 12 months(baseline and 12 months)

Study Sites (1)

Loading locations...

Similar Trials